Literature DB >> 29886270

Crosstalk between type I and II interferons in regulation of myeloid cell responses during bacterial infection.

William J Crisler1, Laurel L Lenz2.   

Abstract

Type I and type II interferons (IFNα/β and IFNγ) are cytokines that play indispensable roles in directing myeloid cell activity during inflammatory and immune responses. Each IFN type binds a distinct receptor (IFNAR or IFNGR) to transduce signals that reshape gene expression and function of myeloid and other cell types. In the context of murine models and human bacterial infections, production of IFNγ generally promotes resistance while production of IFNα/β is associated with increased host susceptibility. Here, we review mechanisms of crosstalk between type I and II IFNs in myeloid cells and their impact on myeloid cell activation and anti-microbial function.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29886270      PMCID: PMC6348002          DOI: 10.1016/j.coi.2018.05.014

Source DB:  PubMed          Journal:  Curr Opin Immunol        ISSN: 0952-7915            Impact factor:   7.486


  70 in total

1.  DNA binding controls inactivation and nuclear accumulation of the transcription factor Stat1.

Authors:  Thomas Meyer; Andreas Marg; Petra Lemke; Burkhard Wiesner; Uwe Vinkemeier
Journal:  Genes Dev       Date:  2003-08-15       Impact factor: 11.361

2.  Detrimental Type I Interferon Signaling Dominates Protective AIM2 Inflammasome Responses during Francisella novicida Infection.

Authors:  Qifan Zhu; Si Ming Man; Rajendra Karki; R K Subbarao Malireddi; Thirumala-Devi Kanneganti
Journal:  Cell Rep       Date:  2018-03-20       Impact factor: 9.423

Review 3.  Interferon-stimulated genes: a complex web of host defenses.

Authors:  William M Schneider; Meike Dittmann Chevillotte; Charles M Rice
Journal:  Annu Rev Immunol       Date:  2014-02-06       Impact factor: 28.527

4.  Tissue-specific targeting of cytokine unresponsiveness in transgenic mice.

Authors:  A S Dighe; D Campbell; C S Hsieh; S Clarke; D R Greaves; S Gordon; K M Murphy; R D Schreiber
Journal:  Immunity       Date:  1995-11       Impact factor: 31.745

5.  B Cells Producing Type I IFN Modulate Macrophage Polarization in Tuberculosis.

Authors:  Alan Bénard; Imme Sakwa; Pablo Schierloh; André Colom; Ingrid Mercier; Ludovic Tailleux; Luc Jouneau; Pierre Boudinot; Talal Al-Saati; Roland Lang; Jan Rehwinkel; Andre G Loxton; Stefan H E Kaufmann; Véronique Anton-Leberre; Anne O'Garra; Maria Del Carmen Sasiain; Brigitte Gicquel; Simon Fillatreau; Olivier Neyrolles; Denis Hudrisier
Journal:  Am J Respir Crit Care Med       Date:  2018-03-15       Impact factor: 21.405

6.  Type I IFN induces IL-10 production in an IL-27-independent manner and blocks responsiveness to IFN-γ for production of IL-12 and bacterial killing in Mycobacterium tuberculosis-infected macrophages.

Authors:  Finlay W McNab; John Ewbank; Ashleigh Howes; Lucia Moreira-Teixeira; Anna Martirosyan; Nico Ghilardi; Margarida Saraiva; Anne O'Garra
Journal:  J Immunol       Date:  2014-09-03       Impact factor: 5.422

7.  The EBV-encoded latent membrane proteins, LMP2A and LMP2B, limit the actions of interferon by targeting interferon receptors for degradation.

Authors:  K M Shah; S E Stewart; W Wei; C B J Woodman; J D O'Neil; C W Dawson; L S Young
Journal:  Oncogene       Date:  2009-08-31       Impact factor: 9.867

8.  Lymphocytes are detrimental during the early innate immune response against Listeria monocytogenes.

Authors:  Javier A Carrero; Boris Calderon; Emil R Unanue
Journal:  J Exp Med       Date:  2006-03-20       Impact factor: 14.307

9.  Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity.

Authors:  C F Nathan; H W Murray; M E Wiebe; B Y Rubin
Journal:  J Exp Med       Date:  1983-09-01       Impact factor: 14.307

10.  Functional Interplay between Type I and II Interferons Is Essential to Limit Influenza A Virus-Induced Tissue Inflammation.

Authors:  Sebastian A Stifter; Nayan Bhattacharyya; Roman Pillay; Manuela Flórido; James A Triccas; Warwick J Britton; Carl G Feng
Journal:  PLoS Pathog       Date:  2016-01-05       Impact factor: 6.823

View more
  9 in total

1.  IFNs Reset the Differential Capacity of Human Monocyte Subsets to Produce IL-12 in Response to Microbial Stimulation.

Authors:  Alice Muglia Amancio; Lara Mittereder; Alexie Carletti; Kevin W Tosh; Daniel Green; Lis R Antonelli; Ricardo T Gazzinelli; Alan Sher; Dragana Jankovic
Journal:  J Immunol       Date:  2021-02-24       Impact factor: 5.422

Review 2.  Pathogenic Biohacking: Induction, Modulation and Subversion of Host Transcriptional Responses by Listeria monocytogenes.

Authors:  Matthew J G Eldridge; Pascale Cossart; Mélanie A Hamon
Journal:  Toxins (Basel)       Date:  2020-05-05       Impact factor: 4.546

Review 3.  Role of Type I Interferon (IFN) in the Respiratory Syncytial Virus (RSV) Immune Response and Disease Severity.

Authors:  Diego R Hijano; Luan D Vu; Lawrence M Kauvar; Ralph A Tripp; Fernando P Polack; Stephania A Cormier
Journal:  Front Immunol       Date:  2019-03-26       Impact factor: 7.561

4.  Malaria abrogates O'nyong-nyong virus pathologies by restricting virus infection in nonimmune cells.

Authors:  Anthony Torres-Ruesta; Teck-Hui Teo; Yi-Hao Chan; Siti Naqiah Amrun; Nicholas Kim-Wah Yeo; Cheryl Yi-Pin Lee; Samantha Yee-Teng Nguee; Matthew Zirui Tay; Francois Nosten; Siew-Wai Fong; Fok-Moon Lum; Guillaume Carissimo; Laurent Renia; Lisa Fp Ng
Journal:  Life Sci Alliance       Date:  2022-01-17

5.  The Unitary Micro-Immunotherapy Medicine Interferon-γ (4 CH) Displays Similar Immunostimulatory and Immunomodulatory Effects than Those of Biologically Active Human Interferon-γ on Various Cell Types.

Authors:  Camille Jacques; Mathias Chatelais; Karim Fekir; Adrien Brulefert; Ilaria Floris
Journal:  Int J Mol Sci       Date:  2022-02-19       Impact factor: 5.923

6.  Role of the transcriptional regulator SP140 in resistance to bacterial infections via repression of type I interferons.

Authors:  Daisy X Ji; Kristen C Witt; Dmitri I Kotov; Shally R Margolis; Alexander Louie; Victoria Chevée; Katherine J Chen; Moritz M Gaidt; Harmandeep S Dhaliwal; Angus Y Lee; Stephen L Nishimura; Dario S Zamboni; Igor Kramnik; Daniel A Portnoy; K Heran Darwin; Russell E Vance
Journal:  Elife       Date:  2021-06-21       Impact factor: 8.140

7.  Ligand-induced IFNGR1 down-regulation calibrates myeloid cell IFNγ responsiveness.

Authors:  William J Crisler; Emily M Eshleman; Laurel L Lenz
Journal:  Life Sci Alliance       Date:  2019-10-04

Review 8.  Inflammation as a Modulator of Host Susceptibility to Pulmonary Influenza, Pneumococcal, and Co-Infections.

Authors:  Elizabeth R Aguilera; Laurel L Lenz
Journal:  Front Immunol       Date:  2020-02-11       Impact factor: 7.561

9.  Myeloid cell responsiveness to interferon-gamma is sufficient for initial resistance to Listeria monocytogenes.

Authors:  Emily M Eshleman; Nikki Bortell; Daniel S McDermott; William J Crisler; Laurel L Lenz
Journal:  Curr Res Immunol       Date:  2020-02-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.